GGrantIndex
← Leaderboards

Pharmacology Discovery Services Taiwan, Ltd.

New Taipei City

Compare ↔
$7,682,701
Total funding
2
Grants

Funding over time

peak $1.6M · FY202025
$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,682,701 · 2

By mechanism

N01$7,682,701 · 2

Investigators at Pharmacology Discovery Services Taiwan, Ltd.

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

Not enough data

All-Time

Most funded here, all years

Not enough data

Largest grants

Task A42: Therapeutic Testing in Murine Models of Bacterial Thigh, Lung and Peritonitis Infections$760,250
N01 · FY2020 · AI
Task A58: Therapeutic Testing in Murine Models of Bacterial Thigh, Lung, Bacteremia and Peritonitis Infections$738,430
N01 · FY2021 · AI
Task A 87: Therapeutic Testing in Murine Models of Bacterial Infection$684,053
N01 · FY2023 · AI
Task A75: Therapeutic Testing in Murine Models of Bacterial Infections$598,380
N01 · FY2022 · AI
Task A87: Therapeutic Testing in Murine Models of Antibiotic-Resistant Bacterial Infection$554,966
N01 · FY2024 · AI
Task A57: Pharmacokinetics (PK) Studies of Therapeutic Bacteriophage in Murine Models of Pseudomonas aeruginosa Infections$506,383
N01 · FY2022 · AI
Task A94: Testing in Murine Models of Antibiotic-Resistant Bacterial Infection$503,403
N01 · FY2024 · AI
Task A41: Therapeutic Testing in Murine Models of Pseudomonas Lung Infection and Murine Models of Bacteremia and Peritonitis$385,682
N01 · FY2020 · AI
Task A50: Murine Models of UTI Infection Caused by Antibiotic-Resistant Bacteria$360,516
N01 · FY2021 · AI
Task A100: Mouse Model of Neisseria Gonorrhoeae Antibiotic Resistant Infection$331,260
N01 · FY2024 · AI
Task A82: MURINE MODELS OF UTI INFECTION CAUSED BY ANTIBIOTIC-RESISTANT BACTERIA$315,860
N01 · FY2023 · AI
Task A67: Murine Models of UTI Caused by Antibiotic-Resistant Bacteria$297,797
N01 · FY2022 · AI
Task A75: Therapeutic Testing in Murine Models of Bacterial Infections$278,470
N01 · FY2023 · AI
Task A42: Therapeutic Testing in Murine Models of Bacterial Thigh, Lung and Peritonitis Infections$190,654
N01 · FY2021 · AI
Task A57: Pharmacokinetics (PK) Studies of Therapeutic Bacteriophage in Murine Models of Pseudomonas aeruginosa Infections$174,460
N01 · FY2021 · AI
Task A75: Therapeutic Testing in Murine Models of Bacterial Infections$165,060
N01 · FY2023 · AI
Task A75: Therapeutic Testing in Murine Models of Bacterial Infections$163,510
N01 · FY2023 · AI
Task A82: Murine Models of UTI Caused by Antibiotic-Resistant Bacteria$141,700
N01 · FY2024 · AI
Task A82: Murine Models of UTI Caused by Antibiotic-Resistant Bacteria$141,700
N01 · FY2025 · AI
Task A58: Therapeutic Testing in Murine Models of Bacterial Thigh, Lung, Bacteremia and Peritonitis Infections$132,550
N01 · FY2022 · AI